In 2023, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) recommended ...

Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

Respiratory syncytial virus (RSV) remains the top cause of hospitalization among young children, leading to respiratory ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

COVID-19, influenza and RSV are the main threats between October and May. There are vaccines for all three viruses, so you ...

Clinician-scientists analyzed samples from patients' airways and blood, finding distinct changes in children with severe cases of RSV, including an increase in the number of natural killer (NK) cells ...

There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...

Adults who are at risk of severe RSV are 75 years or older. Also, people between 60 and 74 years old who have chronic health ...

As the days grow cooler, families across Utah are reminded that respiratory viruses, particularly Respiratory Syncytial Virus ...

Study compares immediate post-discharge care requirements for respiratory syncytial virus (RSV), influenza, acute myocardial ...